Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM2 | O94759 | 3/20 | 0.81 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.81 |
| ▸ | TRPA1 | O75762 | 7/20 | 0.79 |
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.79 |
| ▸ | MEN1 | O00255 | 3/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | NPC1 | O15118 | 2/20 | 0.73 |
| ▸ | RAB9A | P51151 | 2/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.73 |
| ▸ | MAPT | P10636 | 1/20 | 0.73 |
| ▸ | MMP1 | P03956 | 8/20 | 0.73 |
| ▸ | MMP2 | P08253 | 8/20 | 0.73 |
| ▸ | MMP9 | P14780 | 8/20 | 0.73 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.65 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.65 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | TP53 | P04637 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2778920 | 1.00 | TRPM2 (0.81) | TRPM2LTB4RTRPA1TRPM8MEN1 | |
| SCHEMBL2778922 | 1.00 | TRPM2 (0.81) | TRPM2LTB4RTRPA1TRPM8MEN1 | |
| SCHEMBL294402 | 0.92 | TRPM2 (0.83) | TRPM2LTB4RTRPA1TRPM8MEN1 | |
| SCHEMBL294403 | 0.92 | TRPM2 (0.83) | TRPM2LTB4RTRPA1TRPM8MEN1 | |
| SCHEMBL28809051 | 0.90 | TRPM2 (1.00) | TRPM2LTB4RTRPA1TRPM8MEN1 | |
| SCHEMBL28809046 | 0.90 | TRPM2 (1.00) | TRPM2LTB4RTRPA1TRPM8MEN1 | |
| SCHEMBL2780806 | 0.88 | TRPA1 (1.00) | TRPM2LTB4RTRPA1TRPM8MEN1 | |
| SCHEMBL2780699 | 0.88 | TRPA1 (1.00) | TRPM2LTB4RTRPA1TRPM8MEN1 | |
| SCHEMBL2780698 | 0.88 | TRPA1 (1.00) | TRPM2LTB4RTRPA1TRPM8MEN1 | |
| SCHEMBL2779997 | 0.88 | TRPA1 (1.00) | TRPM2LTB4RTRPA1TRPM8MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005520-A | Application of avenanthramide D in preparation of angiogenesis inhibiting drugs | 桂林医科大学第一附属医院 | 2026-05-12 | — | — | CN | claimed |
| US-20230096303-A1 | A Consumable Product Comprising Malted Cereals for Promoting Recovery at Physical Activity | LANTMÄNNEN FUNCTIONAL FOODS AB (SE) | 2023-03-30 | — | — | US | claimed |
| EP-4125984-A1 | A CONSUMABLE PRODUCT COMPRISING MALTED CEREALS FOR PROMOTING RECOVERY AT PHYSICAL ACTIVITY | Lantmännen Functional Foods AB (SE) | 2023-02-08 | — | — | EP | claimed |
| CN-115605214-A | Consumable product comprising malted cereals for promoting recovery of physical activity | 兰特门内保健食品公司（SE） | 2023-01-13 | — | — | CN | claimed |
| WO-2022128052-A1 | MEDICAMENT FOR FIGHTING INFLAMMATORY CONDITIONS OF HUMAN SKIN | SYMRISE AG (DE) | 2022-06-23 | — | — | WO | claimed |
| EP-4103144-B1 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-05-27 | — | — | EP | disclosed |
| CN-122005520-A | Application of avenanthramide D in preparation of angiogenesis inhibiting drugs | 桂林医科大学第一附属医院 | 2026-05-12 | — | — | CN | disclosed |
| CN-122005520-A | Application of avenanthramide D in preparation of angiogenesis inhibiting drugs | 桂林医科大学第一附属医院 | 2026-05-12 | — | — | CN | disclosed |
| CN-122005520-A | Application of avenanthramide D in preparation of angiogenesis inhibiting drugs | 桂林医科大学第一附属医院 | 2026-05-12 | — | — | CN | disclosed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4110277-B1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-3045161-B1 | Use of active mixtures of 1,2-hexanediol and 1,2-octanediol in cosmetic, pharmaceutical or dermatological emulsions | SYMRISE AG (DE) | 2026-03-25 | — | — | EP | disclosed |
| WO-2022122131-A1 | COMPOSITIONS COMPRISING LIPOPHILIC COMPOUNDS AND ONE OR MORE (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | disclosed |
| WO-2022122135-A1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | disclosed |
| US-20220175859-A1 | Tetraselmis Extract | SYMRISE AG (DE) | 2022-06-09 | — | — | US | disclosed |
| US-11352587-B2 | Fragrance mixtures | SYMRISE AG (DE) | 2022-06-07 | — | — | US | disclosed |
| WO-2022111829-A1 | ESSENTIAL OILS OF CITRUS FRUITS FOR USE AS MEDICAMENT FOR INDUCED, INCREASED AND/OR ACCELERATED AUTOPHAGY IN HUMAN KERATINOCYTES | SYMRISE AG (DE) | 2022-06-02 | — | — | WO | disclosed |
| CN-109475120-B | Antimicrobial compositions | 西姆莱斯股份公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-108366932-B | Method for inhibiting or masking fishy smell | 西姆莱斯股份公司 | 2022-03-15 | — | — | CN | disclosed |
| US-20220054378-A1 | COMPOSITIONS COMPRISING ODORLESS 1,2-PENTANEDIOL | SYMRISE AG (DE) | 2022-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352587-B2 | Fragrance mixtures | DHCR24, FAM120A, TRPA1 | TRPM2 211/4885LTB4R 443/4885TRPA1 3/4885 |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | TRPM2 4334/4885LTB4R 4657/4885TRPA1 3165/4885 |
| US-20220175859-A1 | Tetraselmis Extract | DPM1, CD63, PTPMT1 | TRPM2 275/4885LTB4R 3231/4885TRPA1 656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.